Burkhard C. Schmidt

Munich, BY, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 21 publications

Prospective, non-interventional study of ruxolitinib therapy in patients with polycythaemia vera - German real-world data (PaVe study).

Prospective, non-interventional study of ruxolitinib therapy in patients with polycythaemia vera - German real-world data (PaVe study).

Journal: Annals of hematology

Published: October 22, 2025

Hypomethylating Therapy With or Without Eltrombopag in Elderly Patients With Acute Myeloid Leukemia: Results From the Randomized, Placebo-Controlled Phase 2 DELTA Trial.

Hypomethylating Therapy With or Without Eltrombopag in Elderly Patients With Acute Myeloid Leukemia: Results From the Randomized, Placebo-Controlled Phase 2 DELTA Trial.

Journal: American journal of hematology

Published: June 25, 2025

Ixazomib maintenance therapy in transplant-eligible multiple myeloma: real-world evidence from three large German centers.

Ixazomib maintenance therapy in transplant-eligible multiple myeloma: real-world evidence from three large German centers.

Journal: Haematologica

Published: June 24, 2025

How I diagnose and treat patients in the pre-fibrotic phase of primary myelofibrosis (pre-PMF) - practical approaches of a German expert panel discussion in 2024.

How I diagnose and treat patients in the pre-fibrotic phase of primary myelofibrosis (pre-PMF) - practical approaches of a German expert panel discussion in 2024.

Journal: Annals of hematology

Published: December 04, 2024

Outcomes of anti-programmed death 1 treatment for relapsed/refractory Hodgkin lymphoma: A German Hodgkin Study Group multicentre real-world analysis.

Outcomes of anti-programmed death 1 treatment for relapsed/refractory Hodgkin lymphoma: A German Hodgkin Study Group multicentre real-world analysis.

Journal: British journal of haematology

Published: February 02, 2022

Elevated RIPK3 correlates with disease burden in myelofibrosis.

Elevated RIPK3 correlates with disease burden in myelofibrosis.

Journal: Blood advances

Published: December 31, 2021

The SALT-Readout ASIC for Silicon Strip Sensors of Upstream Tracker in the Upgraded LHCb Experiment.

The SALT-Readout ASIC for Silicon Strip Sensors of Upstream Tracker in the Upgraded LHCb Experiment.

Journal: Sensors (Basel, Switzerland)

Published: November 16, 2021

The HEV Ventilator: at the interface between particle physics and biomedical engineering.

The HEV Ventilator: at the interface between particle physics and biomedical engineering.

Journal: Royal Society open science

Published: October 05, 2021

Characteristics and outcomes of patients with cancer and COVID-19: results from a cohort study.

Characteristics and outcomes of patients with cancer and COVID-19: results from a cohort study.

Journal: Acta oncologica (Stockholm, Sweden)

Published: January 05, 2021

Real-world non-interventional long-term post-authorisation safety study of ruxolitinib in myelofibrosis.

Real-world non-interventional long-term post-authorisation safety study of ruxolitinib in myelofibrosis.

Journal: British journal of haematology

Published: January 16, 2020

Inhibition of PLK1 by capped-dose volasertib exerts substantial efficacy in MDS and sAML while sparing healthy haematopoiesis.

Inhibition of PLK1 by capped-dose volasertib exerts substantial efficacy in MDS and sAML while sparing healthy haematopoiesis.

Journal: European journal of haematology

Published: July 24, 2019

OH defect contents in quartz in a granitic system at 1-5 kbar.

OH defect contents in quartz in a granitic system at 1-5 kbar.

Journal: Contributions to mineralogy and petrology. Beitrage zur Mineralogie und Petrologie

Published: April 19, 2019

Showing 1-12 of 21

Last Updated: 09/26/2026